Hari Mallidi, M.D. (320x240)
Hari R. Mallidi, M.D., F.R.C.S.C.

Hari R. Mallidi, M.D., F.R.C.S.C., associate professor of surgery, has been named Chief of the Division of Transplant and Assist Devices at Baylor College of Medicine. Dr. Mallidi succeeds George P. Noon, M.D., who has brought great distinction and honor to Baylor College of Medicine and to the Division of Transplant and Assist Devices for the 14 years that he has served as its inaugural division chief.

Dr. Mallidi was recruited in 2011 from Stanford University to lead the College’s programs in lung transplantation, adult heart transplantation, and in the surgical management of advanced heart and lung disease. He graduated with honors from the University of Toronto, Faculty of Medicine with a Doctor of Medicine degree in 1997. He subsequently completed a cardiac surgical residency in Toronto and is a Fellow of the Royal College of Surgeons of Canada. After residency, he completed a Cardiothoracic Transplant and Mechanical Circulatory Support Device Fellowship at Stanford University.

Under Dr. Mallidi’s guidance, the lung and heart-lung transplant programs, based at the Baylor St. Luke’s Medical Center, have seen significant growth in volume while achieving outstanding clinical outcomes. Working with O.H. Frazier, M.D., chief of cardiopulmonary transplantation and the Center for Cardiac Support as well as director of Cardiovascular Surgery Research at the Texas Heart Institute, Dr. Mallidi has also been a leading surgeon in the heart transplant and ventricular assist device program at Baylor St. Luke’s Medical Center since his arrival in Houston.

“With the establishment of the new Baylor St. Luke’s Medical Center, we expect that Dr. Mallidi will play a vital role in working with his colleagues in leading the heart-lung transplant and cardiac assist device programs into the future,” stated Department of Surgery Chairman, Dr. Todd Rosengart. “Dr. Mallidi has accomplished much in his brief tenure here already, and I have no doubt that his track record of achievement and excellence will only accelerate with this appointment.”

Dr. Joseph S. Coselli, chief of the Division of Cardiothoracic Surgery at Baylor College of Medicine of which Dr. Mallidi will remain a member, and with whom Dr. Mallidi will be working closely in developing cardiovascular services at Baylor St. Luke’s, stated “It has been a privilege to see Dr. Mallidi work to enhance the success of our transplant and VAD programs. I know the program will continue to prosper as Hari moves into this new position.”

In addition to his BCM responsibilities, Dr. Mallidi holds several leadership positions at the Texas Heart Institute, including Director of the Center for Cardiac Support and Co-Director of the Center for Congenital and Familial Cardiovascular Disease. His additional clinical interests include adult congenital heart surgery, surgery for hypertrophic cardiomyopathy, and valvular heart disease. Dr. Mallidi's research interests are primarily focused on evaluating the outcomes of cardiac surgical procedures and clinical effectiveness research.

Dr. George Noon, an internationally respected pioneer in research and the clinical development of cardiac transplantation and assist devices with over 350 publications to his credit, will remain as an emeritus member of the Department of Surgery Executive Committee, added “It has been a privilege for these many years at Baylor to lead the efforts begun by Dr. DeBakey to innovate and help improve transplant and assist device technology. I am confident that Dr. Mallidi will carry on this legacy.”

Dr. Mallidi affirmed that he plans to “build a multidisciplinary division with cardiologists, intensivists, and surgeons working together in an integrated physician model to advance the treatment of end-stage heart and lung disease. I hope to continue the rich history of the program, the first of its kind in North America, in the challenging modern health care environment that now exists. We hope to further grow a division that will be primed to take full advantage of our wonderful new collaboration with St. Luke’s and Catholic Health Initiatives.”